BioInnovation Institute

Fuse Vectors develops a biotechnology platform that enhances the production of gene therapies. Its innovative cell-free technology enables faster, scalable, and high-quality manufacturing of viral vectors, making gene therapies safer, more efficient, and accessible to patients globally.

Visibuilt specializes in developing and implementing sustainable road-building solutions. It replaces conventional asphalt with innovative, eco-friendly materials. The company's core technology involves a fermentation process that converts waste building materials into a fossil fuel-free binder, significantly reducing the environmental impact of road construction.

ArcanaBio develops advanced diagnostics systems that enable low cast, rapid and scalable biomonitoring for health & wellbeing using biophotonics and AI

NorFalk is a biotechnology company specializing in the production of bio-based, sustainable surfactants for use in consumer everyday products. It operates within the industrial biotech sector, focusing on personal care and household care applications.

Fuse Vectors develops a biotechnology platform that enhances the production of gene therapies. Its innovative cell-free technology enables faster, scalable, and high-quality manufacturing of viral vectors, making gene therapies safer, more efficient, and accessible to patients globally.

Droppet IV develops a medical device that automatically flushes intravenous (IV) sets at the precise moment medication administration ends. This innovation enhances patient care by ensuring optimal treatment and reduces nursing workload.

FÆRM is a food technology company that uses science to advance traditional cheese production methods, paving the way for the future of nondairy products. They re-design plant-masses to mimic the well-known textures and flavors of cheese in order to create taste experiences unlike anything you've ever had.

Zeta Diagnostics develops a non-invasive, portable audio device that aids in the accurate diagnosis of Eustachian tube dysfunction. Its technology monitors patients' ability to equalize middle ear pressure over extended periods, correlating with symptoms to enable timely detection by healthcare professionals.

HHC Medical is a health technology company based in Hillerød, Denmark, that specializes in the development of targeted, non-invasive drug delivery devices using electroporation. Founded in 2019, HHC Medical aims to facilitate localized genetic therapy by enabling the transfection of a significant number of cells rapidly and efficiently. Through its innovative platform, the company addresses the growing need for effective drug delivery solutions in the medical field.

FimmCyte is a biotechnology company focused on developing innovative disease-modifying treatments for fibro-inflammatory diseases, with an initial emphasis on Endometriosis. The company aims to accelerate the path toward a cure for endometriosis by addressing significant healthcare requirements and advancing novel ideas in women's health. FimmCyte's mission is to empower women to take control of their health and meet their unmet medical needs through cutting-edge treatments.

TriptoBIO is a biotechnology research company focused on developing a platform for producing natural plant compounds known as diterpenoids. The company employs synthetic biology techniques to create these compounds through fermentation, which offers several advantages over traditional methods. This approach allows for novel applications of plant diterpenoids while eliminating the need for intensive plant farming and petrochemicals. By doing so, TriptoBIO aims to support environmental health and revolutionize various industries by providing sustainable access to the benefits of plants without depleting natural resources.

Agrobiomics is a company focused on developing innovative natural solutions aimed at enhancing agricultural resilience to climate change and securing a sustainable food supply. By harnessing the potential of soil and cell bacteria, Agrobiomics provides effective methods for farmers to improve crop production, particularly in the face of abiotic stresses like salinity and drought. The company's affordable and potent solutions enable growers worldwide to increase yields, thereby offering sustainable agricultural options that address the challenges posed by changing environmental conditions.

MATR Foods is a food-tech startup focused on creating fungi-based food ingredients. The company specializes in transforming byproducts into healthy food options, utilizing mushrooms, vegetables, and fruits to develop nutritious dishes. MATR Foods emphasizes natural nutrition in its offerings, providing organic vegetables and stuffing for various food products, such as steaks and buns. The company's mission is to deliver healthy food alternatives that are free from additives and not over-processed, catering to consumers seeking wholesome and innovative culinary choices.

SOLID Therapeutics is a biotechnology company focused on developing innovative cancer therapeutics that target both cancer cells and immune cells to treat solid tumors. The company specializes in creating small molecule-based drugs aimed at metabolite G protein-coupled receptors (GPCRs) within the oncology field. By exploring the cell biology of the tumor microenvironment, SOLID Therapeutics employs a dual mode of action to enhance treatment efficacy. This approach is particularly beneficial for patients with breast and pancreatic cancers, as it seeks to reprogram cancer cell metabolism and boost their defense mechanisms, ultimately improving survival outcomes.

Novozymes' Venture is investigating how it may play a vital role in developing and producing cell culture media ingredients at scale for the cultured beef business.

BioHalo is transforming the halogenated chemicals industry by developing more sustainable and bio-based fluorinated polymers and high-performance materials.

metaLead Therapeutics is a biopharmaceutical company focused on developing innovative peptide medications to address metal-related diseases, particularly lead poisoning. The company’s research centers on creating a next-generation treatment that specifically targets and binds lead ions while safeguarding essential metal ions in the body. This targeted approach results in a highly stable medication that can be administered both orally and intravenously. By providing an effective detoxification solution, metaLead Therapeutics aims to improve the health outcomes of individuals affected by lead poisoning on a global scale.

Leopard Biosciences is a biotechnology company focused on advancing molecular diagnostics through its innovative CRISPR platform. This platform enables the multiplex detection of DNA and RNA biomarkers, combining the user-friendly nature of Lateral Flow Assays with the precision and reliability of PCR technology. By empowering healthcare professionals with accessible diagnostic tools at the point of treatment, Leopard Biosciences aims to transform patient care and enhance decision-making in healthcare. The company's mission is to democratize diagnostics, making advanced molecular testing available to both doctors and patients.

Visibuilt specializes in developing and implementing sustainable road-building solutions. It replaces conventional asphalt with innovative, eco-friendly materials. The company's core technology involves a fermentation process that converts waste building materials into a fossil fuel-free binder, significantly reducing the environmental impact of road construction.

Rapidemic is a company focused on the development of molecular point-of-care test kits for the rapid diagnosis of sexually transmitted infections and other infectious diseases. Utilizing proprietary primer technology, Rapidemic's tests enhance sensitivity and specificity while minimizing the need for complex procedures. This innovative approach allows for low-temperature diagnostics, ensuring accuracy and reducing the likelihood of false positives. The company's tests enable clinicians to conduct assessments in various settings, including those with limited medical facilities, providing results within an hour. By facilitating immediate diagnosis, Rapidemic aims to improve patient outcomes and streamline the management of infectious diseases.

Amalus Therapeutics is a biotechnology company focused on developing innovative treatments for cancer and fibrotic disorders. The company aims to enhance patient outcomes by targeting and modulating specific cell types known as fibroblasts, which play a critical role in the formation of abnormal tissue structures associated with various diseases. By harnessing selective fibroblast modulation, Amalus Therapeutics seeks to create transformative therapeutics that address the underlying mechanisms of these conditions, ultimately improving the quality of life for individuals affected by cancer and fibrotic diseases.

Loma Therapeutics is developing targeted immunotherapy for the effective and safe treatment of HPV infection, dysplasia, and cancer patients.

Aiomic is a HealthTech company specializing in AI-enhanced tools to combat postoperative complications. It offers the Surgical Advanced Warning (SAW) system for automated tracking, real-time risk assessment, and personalized patient empowerment.

Founded in 2022, Ousia Pharma is a Danish biotech company dedicated to developing pharmacotherapies for individuals with obesity and metabolic disorders. The company's innovative approach involves using peptides to deliver modulators of synaptic plasticity to the brain, achieving potent and sustained weight loss while maintaining safety.

MELLO specializes in probiotic delivery technology, focusing on micro-encapsulation methods to enhance the effectiveness of probiotics and other sensitive ingredients. The company's innovative approach addresses industry challenges that hinder the optimization of probiotic benefits. By providing advanced micro-encapsulation solutions, MELLO enables clients to create healthier and more sustainable food products, ensuring that sensitive ingredients are effectively protected and delivered.

TetraKit Technologies is a Copenhagen-based company founded in 2021 that specializes in a click chemistry-based radiochemical platform aimed at developing therapeutics for metastatic cancer. The company offers a targeted radionuclide therapy and nuclear imaging platform for cancer diagnosis, utilizing radiopharmaceuticals such as fluorine-18 and astatine-211 for positron emission tomography (PET) imaging and targeted alpha-radionuclide therapy. TetraKit's innovative approach incorporates proprietary click chemistry and a modular design, which allows for rapid and mild labeling conditions across a variety of molecules. This platform enhances the efficiency of production processes in the field of radiopharmaceuticals, enabling medical professionals to leverage advanced technologies in cancer treatment and imaging.

Nordic Virtual Pastures is a Copenhagen-based company developing technologies to accelerate the cultured meat revolution. It proposes a platform around Virtual Media for propagating meat cells, paired with low-cost, sustainable cell growth liquids that support scalable, industrial production. The company aims to address ethical and environmental concerns associated with conventional meat by enabling fully scaled production with reduced cost and resource use. It emphasizes purification of biomass waste streams from existing processes to extract nutrients in a cost-effective, sustainable manner, supporting meat industries to achieve larger-scale facilities. Founded in 2021, the firm positions itself as enabling a more sustainable meat supply through novel cell-culture inputs and waste-stream valorization, targeting the transition away from traditional livestock farming toward cultured meat production.

Agoprene is a material technology company focused on creating sustainable furniture foam from plant fibers, including seaweed and other biomasses. By eliminating petrochemical usage, Agoprene aims to provide the furniture industry with an eco-friendly alternative to traditional oil-based foams. Their innovative products contribute to reducing the environmental impact of furniture manufacturing while promoting sustainability in the sector. The company is accessible for inquiries via mail and has a physical address for direct communication.

Breye Therapeutics, a Danish-based biopharmaceutical firm in the clinical stages, is working to provide cutting-edge oral treatments for the management of retinal vascular diseases.

Agrobiomics is a company focused on developing innovative natural solutions aimed at enhancing agricultural resilience to climate change and securing a sustainable food supply. By harnessing the potential of soil and cell bacteria, Agrobiomics provides effective methods for farmers to improve crop production, particularly in the face of abiotic stresses like salinity and drought. The company's affordable and potent solutions enable growers worldwide to increase yields, thereby offering sustainable agricultural options that address the challenges posed by changing environmental conditions.

FimmCyte is a biotechnology company focused on developing innovative disease-modifying treatments for fibro-inflammatory diseases, with an initial emphasis on Endometriosis. The company aims to accelerate the path toward a cure for endometriosis by addressing significant healthcare requirements and advancing novel ideas in women's health. FimmCyte's mission is to empower women to take control of their health and meet their unmet medical needs through cutting-edge treatments.

MATR Foods is a food-tech startup focused on creating fungi-based food ingredients. The company specializes in transforming byproducts into healthy food options, utilizing mushrooms, vegetables, and fruits to develop nutritious dishes. MATR Foods emphasizes natural nutrition in its offerings, providing organic vegetables and stuffing for various food products, such as steaks and buns. The company's mission is to deliver healthy food alternatives that are free from additives and not over-processed, catering to consumers seeking wholesome and innovative culinary choices.

Heka VR is a company specializing in the development of a virtual reality (VR) platform aimed at providing innovative therapy for individuals suffering from auditory hallucinations, particularly those experiencing malevolent voices. The platform integrates psychology with VR technology to offer a simulation training program and voice modulation techniques. This approach helps patients confront their hallucinations and regain control over their symptoms, offering a viable treatment option for conditions such as treatment-resistant schizophrenia.

Ebumab is a biotechnology research company utilizing AMT technology in combination with the body’s own immune system to fight cancer.

Myco4Food is a biotechnology research company founded in 2022 and headquartered in Copenhagen, Denmark. It focuses on developing protein alternatives and novel food products by upcycling solid waste from the food and agricultural sectors. Utilizing a scalable bioreactor system that employs solid-state fermentation technology, Myco4Food transforms organic waste into protein-rich food ingredients, enzymes, and other valuable materials. The company's innovative approach aims to offer sustainable solutions that reduce carbon emissions and land use within the food industry, while also producing competitively priced alternatives. Through its efforts, Myco4Food contributes to a more sustainable food system by addressing waste and enhancing resource efficiency.

Upstream Foods specializes in producing cell-cultured fats from marine animals, aiming to replicate the taste, texture, and health benefits of traditional seafood. Their unique differentiation technology enables efficient production of fat cells, enhancing plant-based protein products.

TriptoBIO is a biotechnology research company focused on developing a platform for producing natural plant compounds known as diterpenoids. The company employs synthetic biology techniques to create these compounds through fermentation, which offers several advantages over traditional methods. This approach allows for novel applications of plant diterpenoids while eliminating the need for intensive plant farming and petrochemicals. By doing so, TriptoBIO aims to support environmental health and revolutionize various industries by providing sustainable access to the benefits of plants without depleting natural resources.

HHC Medical is a health technology company based in Hillerød, Denmark, that specializes in the development of targeted, non-invasive drug delivery devices using electroporation. Founded in 2019, HHC Medical aims to facilitate localized genetic therapy by enabling the transfection of a significant number of cells rapidly and efficiently. Through its innovative platform, the company addresses the growing need for effective drug delivery solutions in the medical field.

Founded in 2021 and headquartered in Copenhagen, EvodiaBio is a bio-industrial company specializing in the creation of natural, sustainable scents for the food and beverage industries.

Sevenless Therapeutics is a biotechnology company dedicated to developing innovative pharmaceuticals. It employs mathematical techniques to identify novel pain signaling targets and validates these discoveries with data, aiming to provide safe and effective treatments for patients with inadequately treated chronic pain.

MyoPax develops advanced regenerative therapies using stem cells to address debilitating muscle illnesses.

SpaceM develops tools for computational biology to picture metabolism in time and space across spatial scales from organisms to tissues to single cells.

Algiecel is a company focused on addressing CO2 emissions through innovative carbon capture technology by cultivating microalgae. Utilizing a compact and modular photobioreactor system, Algiecel transforms CO2 emissions and LED light into nutrient-rich microalgae biomass and oxygen. This plug-and-play reactor can be easily installed and is designed for scalability, making it suitable for small and mid-sized industrial clients, particularly in the biogas and fermentation sectors. Algiecel's business model not only emphasizes the capture of CO2 but also creates a profitable opportunity through revenue sharing derived from the sale of microalgae biomass and carbon credits. By providing a low-footprint solution, Algiecel aims to support decarbonization efforts while meeting the growing demand for sustainable ingredients in feed, food, and cosmetics industries.

Probmet is a precision oncology therapeutics company founded in 2022 and based in Copenhagen, Denmark. The company focuses on developing targeted treatments specifically for breast cancer and patients with brain metastases. By leveraging advanced therapeutic platforms, Probmet aims to provide effective solutions for these life-threatening conditions, ultimately helping patients to manage their illnesses and improve their quality of life.

TetraKit Technologies is a Copenhagen-based company founded in 2021 that specializes in a click chemistry-based radiochemical platform aimed at developing therapeutics for metastatic cancer. The company offers a targeted radionuclide therapy and nuclear imaging platform for cancer diagnosis, utilizing radiopharmaceuticals such as fluorine-18 and astatine-211 for positron emission tomography (PET) imaging and targeted alpha-radionuclide therapy. TetraKit's innovative approach incorporates proprietary click chemistry and a modular design, which allows for rapid and mild labeling conditions across a variety of molecules. This platform enhances the efficiency of production processes in the field of radiopharmaceuticals, enabling medical professionals to leverage advanced technologies in cancer treatment and imaging.

Warburg Oncology develops novel and innovative therapeutic principles focusing on the inhibition of tumor-cell metabolism and immune evasion.

MELLO specializes in probiotic delivery technology, focusing on micro-encapsulation methods to enhance the effectiveness of probiotics and other sensitive ingredients. The company's innovative approach addresses industry challenges that hinder the optimization of probiotic benefits. By providing advanced micro-encapsulation solutions, MELLO enables clients to create healthier and more sustainable food products, ensuring that sensitive ingredients are effectively protected and delivered.

Nordic Virtual Pastures is a Copenhagen-based company developing technologies to accelerate the cultured meat revolution. It proposes a platform around Virtual Media for propagating meat cells, paired with low-cost, sustainable cell growth liquids that support scalable, industrial production. The company aims to address ethical and environmental concerns associated with conventional meat by enabling fully scaled production with reduced cost and resource use. It emphasizes purification of biomass waste streams from existing processes to extract nutrients in a cost-effective, sustainable manner, supporting meat industries to achieve larger-scale facilities. Founded in 2021, the firm positions itself as enabling a more sustainable meat supply through novel cell-culture inputs and waste-stream valorization, targeting the transition away from traditional livestock farming toward cultured meat production.

Founded in 2022, Ousia Pharma is a Danish biotech company dedicated to developing pharmacotherapies for individuals with obesity and metabolic disorders. The company's innovative approach involves using peptides to deliver modulators of synaptic plasticity to the brain, achieving potent and sustained weight loss while maintaining safety.

Algiecel is a company focused on addressing CO2 emissions through innovative carbon capture technology by cultivating microalgae. Utilizing a compact and modular photobioreactor system, Algiecel transforms CO2 emissions and LED light into nutrient-rich microalgae biomass and oxygen. This plug-and-play reactor can be easily installed and is designed for scalability, making it suitable for small and mid-sized industrial clients, particularly in the biogas and fermentation sectors. Algiecel's business model not only emphasizes the capture of CO2 but also creates a profitable opportunity through revenue sharing derived from the sale of microalgae biomass and carbon credits. By providing a low-footprint solution, Algiecel aims to support decarbonization efforts while meeting the growing demand for sustainable ingredients in feed, food, and cosmetics industries.

FLASH Diagnostics is a Copenhagen-based company founded in 2021 that specializes in 3D histopathology for cancer diagnosis. The company focuses on employing three-dimensional screening techniques to analyze complete cancer resections, allowing for the precise quantification of cancer spread and accurate patient staging. By enhancing traditional microscopy methods, FLASH Diagnostics aims to improve the accuracy of cancer diagnoses, ultimately benefiting medical practitioners and their patients in the clinical setting.

Founded in 2021, Commit Biologics is a Danish biotechnology company dedicated to developing innovative immunotherapy platforms for cancer treatment. Its proprietary platform employs b-specific domain antibodies to engage the body's innate immune response, targeting and destroying cancer cells.

Ampa Medical is a medical technology company that develops and provides solutions for individuals living with an ostomy. It offers a device that serves as an alternative to traditional stoma bags, designed to reduce the time, mental burden, and physical challenges associated with ostomy care. By focusing on improving quality of life for ostomy patients, Ampa Medical addresses an unmet need in ostomy management and seeks to simplify and improve daily living for users.

Stimuliver is a biotechnology company established in 2021 and located in Copenhagen, Denmark. The company specializes in developing a groundbreaking 3D liver implant designed to address critically failing liver function in patients. This innovative technology involves the implantation of lab-engineered tissue, produced from human stem cells, beneath the skin to augment the patient's diminished liver capabilities. By offering a potential solution for individuals suffering from chronic liver disease, Stimuliver aims to enhance recovery outcomes and improve the quality of life for those affected by severe liver conditions.

HEI Therapeutics is a digital therapeutics company focused on developing medical-grade home monitoring solutions specifically for thyroid conditions, particularly hypothyroidism. Utilizing advanced microfluidics, microtechnology, and artificial intelligence, the company aims to empower patients in managing their health. By collaborating closely with patients and clinicians, HEI Therapeutics creates innovative solutions that facilitate continuous care, enhancing the overall patient experience and improving health outcomes.

Pephexia Therapeutics is a biotechnology company focused on the discovery and development of innovative peptide-based pharmacotherapies aimed at treating cachexia, sarcopenia, and related diseases. By leveraging naturally occurring peptide hormones, the company provides effective treatment options that enhance the quality of life for patients suffering from chronic conditions such as pulmonary, heart, and kidney diseases. Through its research and development efforts, Pephexia Therapeutics aims to address the unmet medical needs associated with these debilitating conditions.

Notify Therapeutics is a biotechnology company focused on developing innovative therapies for infertility. Specifically, it targets the early, hormone-independent phase of egg maturation, aiming to create a first-in-class treatment for women who do not respond to standard hormone therapy. The company's approach involves utilizing drug-inducing factors that regulate the intracellular AKT pathway, facilitating ovarian follicle development. This non-hormonal treatment is particularly designed to assist women with low ovarian reserves, enhancing their chances of successful conception while minimizing the risks associated with multiple pregnancies.

Orbit Health specializes in developing artificial intelligence solutions for personalized treatment of Parkinson's disease.

Embark Biotech is an early-stage biotechnology company based in Copenhagen, Denmark, founded in 2017. The company focuses on identifying novel cell surface receptors that play a critical role in regulating calorie-burning in fat tissue, as well as the uptake of glucose and lipids. By developing receptors that stimulate energy expenditure without activating the sympathetic nervous system, Embark Biotech aims to address unmet clinical needs in the field of metabolic diseases.

Bioomix is a biotechnology company that develops all-natural microbial products that can help farmers achieve a higher and better yield. It was founded in 2021 and its headquarters is located in Odense, Denmark.

Kesmalea Therapeutics is a biotechnology company specializing in the discovery of novel protein degraders. It offers an alternative approach for therapeutics with 'PROTAC-like' actions, aiming to transform large protein degraders into small molecules for targeted protein degradation.

Enduro Genetics is a technology provider that specializes in enhancing large-scale fermentations through its proprietary synthetic biology technology. The company focuses on improving the performance of fermentation processes by developing a genetic plugin technology that is free of antibiotic resistance genes. This innovation allows for higher yields by enriching spontaneous high producers within the fermentation population, facilitating the production of complex or cellular inhibit products by addressing strain instability. By maximizing the performance of cells derived from production strains, Enduro aims to bolster the competitiveness of both current and future green bioproduction initiatives.

Founded in 2018, Sundew is a biotechnology company based in Copenhagen. It specializes in providing biological services for treating aquatic pests and diseases using precision fermentation.

Ciana Therapeutics is a clinical development-stage company based in Copenhagen, Denmark, established in 2019. The company specializes in creating innovative therapies aimed at treating diabetic retinopathy, a complication of diabetes that can lead to vision loss and blindness. Ciana's therapeutic approach involves a novel treatment that stabilizes and protects retinal capillaries, thereby preventing structural breakdown, vascular leakage, and retinal edema. Through its research and development efforts, Ciana Therapeutics aims to provide effective solutions for patients suffering from the visual impairments associated with diabetes.

Ward 24/7 is a Copenhagen-based company that specializes in digital health solutions aimed at enhancing patient care through continuous monitoring of respiratory and circulatory distress. Founded in 2016, the company has developed an intelligent clinical support system that utilizes a network of wireless sensors to track vital parameters such as oxygen saturation, respiratory rate, and cardiac function in high-risk patients. This system employs artificial intelligence to analyze real-time data, allowing for early detection of potential health issues and timely intervention by healthcare professionals. By providing 24/7 observation and alerting staff to critical situations, Ward 24/7 aims to improve the efficiency and effectiveness of hospital care, ultimately enhancing patient outcomes.

BOOST Pharma is a biotechnology research company based in Copenhagen, Denmark, founded in 2019. The company specializes in developing a stem cell therapy aimed at treating osteogenesis imperfecta, a genetic disorder characterized by fragile bones. BOOST Pharma's innovative approach utilizes novel mesenchymal stem cells known for their strong bone-forming capabilities. Once injected into patients, these stem cells migrate to the bone, where they engraft and initiate the process of bone formation. This therapeutic strategy enables clinicians to address the disease at its earliest stages, potentially enhancing long-term outcomes for patients.

Lophora is a biopharmaceutical company focused on developing rapid-acting treatments for central nervous system diseases, particularly treatment-resistant depression. The company has discovered and patented a novel class of proprietary ligands that exhibit a pharmacological profile akin to psilocybin, which has shown promising results in clinical settings. In addition to targeting depression, Lophora's innovative drug class holds potential for addressing various other CNS disorders, including anxiety, post-traumatic stress disorder, and substance abuse. Through its pioneering approach to psychedelic medicines, Lophora aims to provide effective relief for patients struggling with mental health issues that have not responded to traditional therapies.

PokeAcell is an immunotherapy company focused on developing personalized T-cell therapies for tumor treatment. Utilizing its proprietary ImmPACT activation technology, PokeAcell has created Poke-101, a shared antigen-responding T-cell product that aims to generate durable responses in patients with solid tumors. In addition to its application in oncology, the company's therapies also show potential in addressing various skin diseases, including melanoma. Through its innovative approach, PokeAcell seeks to enhance patient outcomes by enabling better management and prevention of tumor growth.

Paragit Solutions specializes in developing innovative systems for remote patient monitoring and data-driven clinical management of movement disorders, particularly Parkinson's disease. Central to their offerings is the Paragit Sleeve, which employs a patented sEMG (electromyography) technology to gather precise data on muscle activation, movement, and grip force during patients' daily activities. Paragit provides two main software suites for data interpretation: the PD Monitor, tailored for caregivers, which visualizes key motor symptoms like rigidity and tremors to enhance treatment optimization and facilitate telemedicine; and the MD Lab, designed for decentralized clinical trials across various movement disorders. MD Lab enables researchers to analyze over 20 metrics related to disease severity, track trends, and compare groups consistently, with a robust API that supports extensive data access for further analysis. Through these technologies, Paragit aims to improve the management and understanding of movement disorders, enhancing patient care and clinical research.

MedicQuant specializes in developing diagnostic tools for blood anticoagulant properties. Its innovative technology enables direct detection of Direct Oral Anticoagulants (DOACs) from whole blood samples, facilitating rapid and accurate point-of-care testing.

Cirqle Biomedical is a Copenhagen-based biotech company focused on advancing women's health through innovative contraceptive solutions. The company is developing a non-hormonal contraceptive technology that utilizes mucus engineering principles to create a temporary barrier in cervical mucus, preventing sperm from entering the uterus. This approach aims to provide women with greater control over their reproductive choices without the use of traditional hormonal methods. By prioritizing women's freedom and quality of life, Cirqle Biomedical seeks to transform contraceptive options and enhance reproductive health.

Synklino is a biotechnology company specializing in the development of a cytomegalovirus (CMV)-specific immunotoxin aimed at eradicating CMV infections. This innovative immunotoxin is designed to effectively target and eliminate both lytic and latently infected cells, providing rapid relief from the virus. By ensuring fast and safe eradication of CMV infections, Synklino's solution enhances long-term survival prospects for transplant recipients, ultimately contributing to better overall health outcomes for patients undergoing transplantation. The company's focus on addressing CMV infections positions it as a key player in improving post-transplant care and patient quality of life.

Proxi Biotech is a biotechnology company headquartered in Copenhagen, Denmark, founded in 2017. It specializes in developing a bacteria-resistant vaccine aimed at treating multi-drug-resistant bacterial infections. Utilizing its BACTOVAC platform technology, the company focuses on detoxifying bacterial toxins and effectively eliminating multi-drug-resistant bacteria. Proxi Biotech's innovations address significant infectious disease challenges, contributing to improved public health outcomes and enabling patients to maintain healthier lives.

Kariya Pharmaceuticals is a biotechnology company based in Copenhagen, Denmark, founded in 2018. The company focuses on developing innovative drugs aimed at treating neurodegenerative diseases, specifically Parkinson's and Alzheimer's. Its drug candidates utilize dual incretin receptors, which are designed to slow the progression of these conditions, offering potential therapeutic benefits to patients affected by these debilitating diseases.

RetiPharma is a biotechnology company based in Copenhagen, Denmark, focused on developing peptide-based products for the treatment of degenerative eye disorders. The company’s portfolio includes RP001, a peptide drug designed for intravitreal injection, as well as additional peptide drugs RP002 and RP003. These products aim to provide neuroprotective effects in the eye, addressing critical needs in ophthalmic health care.

Founded in 2018, Stipe Therapeutics is a Danish biopharmaceutical company dedicated to harnessing the innate immune system for cancer treatment. It focuses on developing first-in-class drugs targeting intracellular protein-protein interactions of the STING pathway, aiming to modulate the tumor microenvironment and enhance anti-tumoral responses.